Dianthus Therapeutics, Inc. has grown revenue −32% a year over three years. Revenue growth, 3-year annual rate: −32% (Biotechnology median +21%). Years of annual history on file: 10, FY2016 to FY2025, as filed.

DNTHDianthus Therapeutics, Inc.

HealthcareUSD

$110.57

$18.7652 weeks$115.67

Is it growing?

Is DNTH growing?

Dianthus Therapeutics, Inc. has grown revenue −32% a year over three years.

−32%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from fiscal-year columns as filed

Years of annual history on file: 10
Years of annual history on file · FY2016 to FY2025, as filed

Details›

Revenue FY2021: $1.5M
Revenue FY2022: $6.4M
Revenue FY2023: $2.8M
Revenue FY2024: $6.2M
Revenue FY2025: $2.0M

Annual income statements as filed with the SEC.

Biotechnology

Ranks #81 of 145 by Smart Score

Compare peers

MANE+1.8%

Veradermics, Incorporated

TNGX+3.5%

Tango Therapeutics, Inc.

ORKA+5.5%

Oruka Therapeutics, Inc.

CAI+3.0%

Caris Life Sciences, Inc.

CRSP+0.80%

CRISPR Therapeutics AG

CELC-0.47%

Celcuity Inc.